23andMe, the controversial direct-to-consumer seller of genetic testing, has raised another $115 in financing.
http://medcitynews.com/2015/10/23andme-brings-in-115m-in-series-e/?utm_source=MedCity+News+Subscribers&utm_campaign=05a1771e79-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-05a1771e79-408793005&rf=1Two recent reports discuss the state of financing for "digital" health companies.
Read More
